DuPont de Nemours (NYSE:DD – Get Free Report) had its price target boosted by stock analysts at Wells Fargo & Company from $166.00 to $170.00 in a research note issued on Thursday, Benzinga reports. The firm presently has an “overweight” rating on the basic materials company’s stock. Wells Fargo & Company‘s target price would indicate a potential upside of 16.24% from the company’s previous close.
DD has been the topic of several other research reports. Weiss Ratings reissued a “sell (d+)” rating on shares of DuPont de Nemours in a research note on Friday, October 30th. The Goldman Sachs Group dropped their price target on DuPont de Nemours from $159.00 to $153.00 and set a “neutral” rating on the stock in a research report on Wednesday, September 30th. Citigroup increased their target price on shares of DuPont de Nemours from $162.00 to $176.00 and gave the stock a “buy” rating in a report on Wednesday. UBS Group boosted their price target on shares of DuPont de Nemours from $172.00 to $182.00 and gave the company a “buy” rating in a report on Wednesday. Finally, Zacks Research cut shares of DuPont de Nemours from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 17th. Twelve equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $165.88.
Check Out Our Latest Analysis on DuPont de Nemours
DuPont de Nemours Trading Up 0.9%
DuPont de Nemours (NYSE:DD – Get Free Report) last released its quarterly earnings data on Tuesday, November 3rd. The basic materials company reported $2.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.87 by $0.22. The company had revenue of $1.87 billion during the quarter, compared to analysts’ expectations of $1.84 billion. DuPont de Nemours had a net margin of 0.67% and a return on equity of 6.92%. The firm’s quarterly revenue was up 4.1% on a year-over-year basis. During the same period in the previous year, the company earned $1.09 EPS. As a group, research analysts forecast that DuPont de Nemours will post 7.51 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently modified their holdings of the company. Physician Wealth Advisors Inc. boosted its stake in DuPont de Nemours by 223.1% in the third quarter. Physician Wealth Advisors Inc. now owns 210 shares of the basic materials company’s stock valued at $27,000 after acquiring an additional 145 shares in the last quarter. Elevation Wealth Partners LLC increased its position in DuPont de Nemours by 168.5% during the 2nd quarter. Elevation Wealth Partners LLC now owns 239 shares of the basic materials company’s stock valued at $32,000 after buying an additional 150 shares in the last quarter. DHJJ Financial Advisors Ltd. boosted its holdings in DuPont de Nemours by 150.0% in the third quarter. DHJJ Financial Advisors Ltd. now owns 250 shares of the basic materials company’s stock worth $32,000 after acquiring an additional 150 shares in the last quarter. Bangor Savings Bank purchased a new stake in shares of DuPont de Nemours during the third quarter worth about $36,000. Finally, Compass Wealth Management LLC purchased a new stake in shares of DuPont de Nemours during the third quarter worth about $39,000. Hedge funds and other institutional investors own 73.96% of the company’s stock.
DuPont de Nemours News Roundup
Here are the key news stories impacting DuPont de Nemours this week:
- Positive Sentiment: Several analysts raised their valuation targets while maintaining bullish ratings. UBS lifted its target to $182 from $172 and kept a Buy rating; RBC raised its target to $173 from $160 with an Outperform rating; and Wells Fargo increased its target to $170 from $166 while maintaining Overweight. UBS target and rating RBC target and rating Wells Fargo target
- Positive Sentiment: Additional coverage included a new Buy rating and a higher price target from Citigroup, reinforcing the generally constructive analyst view. New Buy rating Citigroup target increase
- Positive Sentiment: Barclays reiterated its Buy rating. The analyst support follows DuPont’s recent quarterly earnings beat: EPS of $2.09 topped the $1.87 consensus, while revenue also exceeded expectations. Shares were reported to have gapped up after the results. Barclays rating Shares gap up after earnings
DuPont de Nemours Company Profile
DuPont de Nemours, Inc is a diversified science and technology company that develops engineered materials and specialty products for industrial and consumer markets. Its offerings are used in applications including electronics, semiconductor manufacturing, water purification, transportation, construction, healthcare, and worker and consumer protection.
The company’s product portfolio has historically included high-performance films, resins, adhesives, engineered polymers, specialty fibers, protective materials, water-treatment membranes, and filtration technologies.
Recommended Stories
- Five stocks we like better than DuPont de Nemours
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.
